Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

NCT07516561 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia, Androgenetic

Interventions

DRUG: APSMNF 1
DRUG: APSMNF 2
DRUG: Eniagor®

Sponsor

Apsen Farmaceutica S.A.